Commonwealth Equity Services’s Matinas BioPharma MTNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-966
| Closed | -$8K | – | 4151 |
|
|
2024
Q2 | $8K | Sell |
966
-20
| -2% | -$166 | ﹤0.01% | 4008 |
|
|
2024
Q1 | $13K | Sell |
986
-20
| -2% | -$264 | ﹤0.01% | 3979 |
|
|
2023
Q4 | $11K | Buy |
1,006
+20
| +2% | +$219 | ﹤0.01% | 3855 |
|
|
2023
Q3 | $6K | Hold |
986
| – | – | ﹤0.01% | 3798 |
|
|
2023
Q2 | $18K | Buy |
986
+401
| +69% | +$7.32K | ﹤0.01% | 3756 |
|
|
2023
Q1 | $13 | Hold |
585
| – | – | ﹤0.01% | 3703 |
|
|
2022
Q4 | $14K | Hold |
585
| – | – | ﹤0.01% | 3623 |
|
|
2022
Q3 | $18K | Hold |
585
| – | – | ﹤0.01% | 3589 |
|
|
2022
Q2 | $23K | Buy |
585
+5
| +0.9% | +$197 | ﹤0.01% | 3561 |
|
|
2022
Q1 | $23K | Hold |
580
| – | – | ﹤0.01% | 3648 |
|
|
2021
Q4 | $29K | Sell |
580
-468
| -45% | -$23.4K | ﹤0.01% | 3576 |
|
|
2021
Q3 | $68K | Buy |
1,048
+318
| +44% | +$20.6K | ﹤0.01% | 3470 |
|
|
2021
Q2 | $28K | Hold |
730
| – | – | ﹤0.01% | 3490 |
|
|
2021
Q1 | $38K | Buy |
730
+150
| +26% | +$7.81K | ﹤0.01% | 3351 |
|
|
2020
Q4 | $39K | Buy |
580
+40
| +7% | +$2.69K | ﹤0.01% | 3146 |
|
|
2020
Q3 | $20K | Hold |
540
| – | – | ﹤0.01% | 3013 |
|
|
2020
Q2 | $20K | Hold |
540
| – | – | ﹤0.01% | 2911 |
|
|
2020
Q1 | $16K | Buy |
540
+180
| +50% | +$5.33K | ﹤0.01% | 2771 |
|
|
2019
Q4 | $40K | Buy |
360
+20
| +6% | +$2.22K | ﹤0.01% | 2817 |
|
|
2019
Q3 | $10K | Hold |
340
| – | – | ﹤0.01% | 2817 |
|
|
2019
Q2 | $14K | Buy |
340
+16
| +5% | +$659 | ﹤0.01% | 2753 |
|
|
2019
Q1 | $17K | Buy |
324
+120
| +59% | +$6.3K | ﹤0.01% | 2711 |
|
|
2018
Q4 | $6K | Hold |
204
| – | – | ﹤0.01% | 2664 |
|
|
2018
Q3 | $9K | Hold |
204
| – | – | ﹤0.01% | 2777 |
|
|
2018
Q2 | $4K | Hold |
204
| – | – | ﹤0.01% | 2762 |
|
|
2018
Q1 | $7K | Hold |
204
| – | – | ﹤0.01% | 2704 |
|
|
2017
Q4 | $12K | Hold |
204
| – | – | ﹤0.01% | 2661 |
|
|
2017
Q3 | $13K | Hold |
204
| – | – | ﹤0.01% | 2543 |
|
|
2017
Q2 | $17K | Buy |
+204
| New | +$17K | ﹤0.01% | 2490 |
|